HF
STAB

Hoxton Financial’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Hoxton Financial’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-15
Closed – – 632
2013
Q2 		$0 Buy
+15
New +$516 ﹤0.01% 640

Other funds holding STAB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
BC
BHR Capital New York $48.6M AUM 3.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Hoxton Financial's STAB Position: Q3 2013 in Review

Hoxton Financial sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q3 2013, closing a stake of 15 shares.

Hoxton Financial first reported a position in STAB in Q2 2013 and held it in 1 quarter. The position peaked at $0 in Q2 2013. 41 funds tracked by Wall St. Rank hold STAB as of Q3 2013.

  • Hoxton Financial reported no remaining Statera Biopharma, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • Hoxton Financial sold 15 Statera Biopharma, Inc. Common Stock shares in Q3 2013.
  • Hoxton Financial first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • Hoxton Financial's Statera Biopharma, Inc. Common Stock position peaked at $0 in Q2 2013.
  • 41 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q3 2013.

Based on Hoxton Financial's 13F filing for Q3 2013, filed 7 Oct 2013.